1-2 of 2
Authors: G. Beck-Wirth
Journal Article
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 7, July 2015, Pages 2084–2089, https://doi.org/10.1093/jac/dkv049
Published: 26 February 2015
Journal Article
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 8, August 2011, Pages 1869–1877, https://doi.org/10.1093/jac/dkr208
Published: 01 June 2011
